SENNA-S- docusate sodium and sennosides tablet, film coated

Senna-S by

Drug Labeling and Warnings

Senna-S by is a Otc medication manufactured, distributed, or labeled by Contract Pharmacy Services-PA. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

DRUG FACTS

ACTIVE INGREDIENT (IN EACH TABLET)

Docusate sodium 50 mg

Sennosides 8.6 mg

PURPOSE

Stool softener & Stimulant laxative

USES

• relieves occasional constipation (irregularity)
• generally causes a bowel movement in 6 to 12 hours

WARNINGS

Do not use

• this product if you are presently taking mineral oil, unless directed by a doctor
• laxative products for more than 1 week unless directed by a doctor

Ask a doctor before use if you have

• stomach pain
• nausea
• vomiting
• a sudden change in bowel habits that persists over 2 weeks

Stop use and ask a doctor if you have

• have rectal bleeding
• fail to have a bowel movement after the use of a laxative

These could be signs of a serious condition

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

DIRECTIONS

• take preferably at bedtime or as directed by a doctor
• if you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed maximum dosage); or decrease dose until you are comfortable

• age	starting dose	maximum dose
  adults and children 12 years and over	2 tablets once a day	4 tablets twice a day
  children 6 to under 12 years	1 tablet once a day	2 tablets twice a day
  children 2 to under 6 years	1/2 tablet once a day	1 tablet twice a day
  children under 2 years	ask a doctor	ask a doctor

OTHER INFORMATION

• each tablet contains: calcium 20 mg, sodium 6 mg (LOW SODIUM)
• TAMPER-EVIDENT: Do not use this product if foil seal on back of blister is cut, torn, broken or missing
• store at 25°C (77°F) excursions permitted between 15°-30°C (59°-86°F)

INACTIVE INGREDIENTS

carnauba wax, colloidal silicon dioxide, croscarmellose sodium, dibasic calcium phosphate dihydrate, D&C yellow #10 aluminum lake, FD&C yellow #6 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium benzoate, stearic acid, tapioca starch1, tartaric acid1, titanium dioxide

1may contain these ingredients

QUESTIONS OR COMMENTS?

call 1-888-838-2872, weekdays, 8 AM-5 PM Eastern Time

Distributed by:
GOLDLINE LABORATORIES, INC.
Sellersville, PA 18960 Dist. 1999 0110REV 89
192B R1009

Repackaged by:

Contract Pharmacy Services-PA
125 Titus Ave Suite 200
Warrington, PA 18976 USA

Original--08/2010--NJW

Package Label

INGREDIENTS AND APPEARANCE

SENNA-S 
docusate sodium and sennosides tablet, film coated

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 67046-670(NDC: 0182-1113)
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG)	DOCUSATE SODIUM	50 mg
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)	SENNOSIDES	8.6 mg

Inactive Ingredients
Ingredient Name	Strength
CARNAUBA WAX (UNII: R12CBM0EIZ)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
HYPROMELLOSE (UNII: 3NXW29V3WO)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
POLYETHYLENE GLYCOL (UNII: 3WJQ0SDW1A)
SODIUM BENZOATE (UNII: OJ245FE5EU)
STEARIC ACID (UNII: 4ELV7Z65AP)
STARCH, TAPIOCA (UNII: 24SC3U704I)
TARTARIC ACID (UNII: W4888I119H)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
ALUMINUM OXIDE (UNII: LMI26O6933)

Product Characteristics
Color	YELLOW	Score	no score
Shape	ROUND	Size	8mm
Flavor		Imprint Code	8
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 67046-670-30	30 in 1 BLISTER PACK

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part334	08/17/2010

Labeler - Contract Pharmacy Services-PA (945429777)